BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33564434)

  • 1. Monoclonal gammopathy of undetermined significance coexisting in patients undergoing kidney transplantation does not adversely influence post-graft clinical outcome.
    Clari R; Tarella C; Giraudi R; Torazza MC; Gallo E; Lavacca A; Fop F; Mella A; Dolla C; Biancone L
    Clin Kidney J; 2021 Jan; 14(1):317-324. PubMed ID: 33564434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal gammopathy of unknown significance in kidney transplanted patients: novel insights into long-term outcomes.
    Meuleman MS; Mouyabi S; Gueguen J; Vicca S; Divard G; Aubert O; Bienaimé F; Arnulf B; Anglicheau D; Bridoux F; Cohen C
    Nephrol Dial Transplant; 2023 Dec; 39(1):64-73. PubMed ID: 37403344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
    Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
    Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy.
    Soltero L; Carbajal H; Xu J; McCarthy J; Suki WN; Gaber AO; Adrogué HE
    Clin Transplant; 2012; 26(2):300-4. PubMed ID: 22044717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up monoclonal gammopathy of undetermined significance in kidney transplant.
    Cuéllar-García C; Sevillano Ruiz-Mateos C; Mazuecos Blanca MA; Narvaez Mejia C; Fernandez Valle MC; Martin Reina V; Gonzalez Bernal M; Yera Cobo M; Rodriguez Lopez R; de Cos Hohr C; Garrastazul MP; Marchante I; Paz Coll A; Capote Huelva FJ
    Transplant Proc; 2015; 47(1):78-80. PubMed ID: 25645776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcome and quality of life in kidney transplant recipient with monoclonal gammopathy.
    Yanishi M; Tsukaguchi H; Yoshida T; Taniguchi H; Yoshida K; Mishima T; Komai Y; Yasuda K; Watanabe M; Sugi M; Kinoshita H; Matsuda T
    CEN Case Rep; 2016 Nov; 5(2):168-172. PubMed ID: 28508971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients.
    Gagnon MF; Cardinal H; Emond JP; Latour M; Lemieux B
    Transplant Direct; 2019 Oct; 5(10):e489. PubMed ID: 31723584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Monoclonal Gammopathy of Undetermined Significance in Patients Who Underwent Kidney Transplantation.
    Bancu I; Cañas L; Juega FJ; Pérez M; Malumbres S; Bonet J; Lauzurica R
    Transplant Proc; 2015 Oct; 47(8):2344-5. PubMed ID: 26518922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
    Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significance.
    Goebel TE; Schiltz NK; Woodside KJ; Pillai AC; Caimi PF; Lazarus HM; Koroukian SM; Campagnaro EL
    Clin Transplant; 2015 Sep; 29(9):851-7. PubMed ID: 26194021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance.
    Aslam N; Trautman CL; Sher T
    Transplant Direct; 2021 Aug; 7(8):e723. PubMed ID: 34263021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
    Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients.
    Steiner N; Göbel G; Suchecki P; Prokop W; Neuwirt H; Gunsilius E
    Oncotarget; 2018 Jan; 9(2):2344-2356. PubMed ID: 29416776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.
    Wadhera RK; Kyle RA; Larson DR; Dispenzieri A; Kumar S; Lazarus HM; Rajkumar SV
    Blood; 2011 Sep; 118(11):2985-7. PubMed ID: 21765020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal Gammopathies After Renal Transplantation: A Single-center Study.
    Bhasin B; Szabo A; Wu R; Saad ER; Hari P; Dhakal B; Chhabra S; D'Souza A
    Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e468-e473. PubMed ID: 32340914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
    Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Cerhan JR; Rajkumar SV
    N Engl J Med; 2018 Jan; 378(3):241-249. PubMed ID: 29342381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.
    Rostaing L; Modesto A; Abbal M; Durand D
    Am J Nephrol; 1994; 14(3):187-91. PubMed ID: 7977478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.